Download App

Log in to access Online Inquiry
Company Overview More
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.
CEO: Hassanein M.D., Waleed H.
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > TMDX TransMedics > Detailed Quotes

TMDX TransMedics

28.010-0.390-1.37%
Close 05/23 20:00 ET
28.01000.00%
Post Mkt Price 05/23 16:30 ET
High
29.080
Open
28.620
Turnover
3.90M
Low
26.900
Pre Close
28.400
Volume
139.72K
Market Cap
783.74M
P/E(TTM)
Loss
52wk High
35.370
Shares
27.98M
P/E(Static)
Loss
52wk Low
10.000
Float Cap
746.20M
Bid/Ask %
33.33%
Historical High
49.500
Shs Float
26.64M
Volume Ratio
0.65
Historical Low
10.000
Dividend TTM
--
Div Yield TTM
--
P/B
13.08
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.52%
Amplitude
7.68%
Avg Price
27.918
Lot Size
1
Float Cap
746.20M
Bid/Ask %
33.33%
Historical High
49.500
Shs Float
26.64M
Volume Ratio
0.65
Historical Low
10.000
Dividend TTM
--
P/B
13.08
Dividend LFY
--
Turnover Ratio
0.52%
Amplitude
7.68%
Avg Price
27.918
Lot Size
1
Price Forecast

No Data

News

Comment